Evidence map›Paper›PMID 37740816›Full record

ArticleInternational journal of hematology2024

Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases.

Shuhei Aoyama, Kohei Fukuoka, Hirohito Kubota, Kotaro Narita, Ko Kudo, Yuichi Mitani, Koichi Oshima, Makiko Mori, Yuki Arakawa, Kayoko Ichimura and 7 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Shuhei AoyamaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Kohei FukuokaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan. kohfukuoka@gmail.com.ORCID http://orcid.org/0000-0003-2568-0877
Hirohito KubotaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Kotaro NaritaDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ko KudoDepartment of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yuichi MitaniDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Koichi OshimaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Makiko MoriDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Yuki ArakawaDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Kayoko IchimuraDepartment of Pathology, Saitama Children's Medical Center, Saitama, Japan.
Kiminori TeruiDepartment of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yutaka TanamiDepartment of Radiology, Saitama Children's Medical Center, Saitama, Japan.
Hiroshi KawashimaDepartment of Pediatric Surgery, Saitama Children's Medical Center, Saitama, Japan.
Atsuko NakazawaDepartment of Pathology, Saitama Children's Medical Center, Saitama, Japan.
Takehiro NiitsuDepartment of Critical Care Medicine, Saitama Children's Medical Center, Saitama, Japan.
Yoshiyuki TakahashiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Katsuyoshi KohDepartment of Hematology/Oncology, Saitama Children's Medical Center, 1-2, Shintoshin, Chuo-ku, Saitama, 330-8777, Japan.
Saitama Children's Medical Center · JPHirosaki University · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid involvement is rare in pediatric Langerhans cell histiocytosis (LCH). It may cause airway narrowing, leading to acute-onset respiratory distress. Severe cases may require emergent surgical interventions such as thyroidectomy, which should be avoided in children due to higher rates of complication, particularly in infancy. There is currently no consensus on the indications for surgical treatment in LCH with thyroid involvement. In this report, we describe the cases of two children who presented with tracheal stenosis caused by thyroid LCH, both of which were successfully treated by early induction of chemotherapy, and one of which was also treated for a shorter duration. Mutation analysis detected in-frame deletions of BRAF exon 12 in both cases. These cases suggest that timely diagnosis and administration of chemotherapy may alleviate severe airway obstruction and reduce the need for thyroidectomy in pediatric patients with thyroid LCH.

Indexed as

Histiocytosis, Langerhans-CellThyroid DiseasesTracheal StenosisChildHumansThyroidectomyChemotherapyLangerhans cell histiocytosisThyroidectomyThyroid involvement

Identifiers

PMID37740816
OpenAlexW4386988763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.